|
|
| FDA OKs Invitrogen genetic test for breast cancer
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Invitrogen Corp's genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin. |
|
|